CorneaGen’s mission is to provide the highest quality donor tissue, unparalleled customer service and superior products that transform how ophthalmologists treat and care for every person impacted by corneal disease. Through continuous innovations in tissue processing technology and surgical devices, advocacy for patient access and simplified payor reimbursement policies, CorneaGen is advancing the next generation of cornea care. As the world’s leading eye bank, CorneaGen has multiple locations and local partnerships throughout the U.S. to deliver the life-changing gift of sight to tens of thousands of people each year.

WELL Health USA, a wholly owned subsidiary of WELL Health Technologies Corp. (TSX: WELL, OTCQX: WHTCF), and our family of US companies, offers omni-channel patient services delivered through ‘bricks and clicks’ healthcare experiences, and best-in-class digital services designed to optimize how healthcare providers in the US practice. WELL Health USA provides its US portfolio of companies with shared services ranging from centralized credentialing, shared recruitment & HR support, collaborative marketing and other corporate support, including billing and accounting, legal and M&A support.

Leaders across Research, Translational Medicine and the Clinic rely on RareCyte as a one-stop resource for Spatial Biology and Liquid Biopsy solutions. Headquartered in Seattle, WA, RareCyte is an innovative precision biology company that has developed technologies and end-to-end integrated platforms enabling advances in oncology, immuno-oncology, maternal-fetal health, and cell and gene therapy. Our highly multiplexed fluorescent imaging systems, reagents and contract services empower investigators to unlock spatial context for key biomarkers and develop therapeutics and companion diagnostics through rare cell analysis.

Creating Solutions to Save Sight for 55 Years! At Ocular, we’re not just driven, we’re customer driven. We focus on serving the needs of every customer. We listen to our customers and continually evolve our products to help them succeed. For over 50 years, we have strived to create and produce ophthalmic lenses of unparalleled sharpness and clarity. And while we have continually challenged ourselves to create breakthrough lens systems at the forefront of the ophthalmic industry, we are committed to continually improving the features and durability of all our product lines, including our more traditional items. We provide innovative solutions that advance the quality of eye care worldwide. As one of the world’s largest suppliers of ophthalmic diagnostic, laser, and surgical lenses, we take our leadership responsibilities seriously. We have developed more than 200 lenses and supporting products for the diagnosis, treatment and surgery of diseases and disorders of the eye. All of our products are developed in conjunction with leading eye doctors around the world and manufactured in our Bellevue, Washington, USA, facility to the most precise and exacting standards. Founded in the 1960’s, Ocular Instruments continues as a family owned and operated business.

How heavy is the load you need to move today? Whatever you are moving, AeroGo can help! AeroGo manufactures innovative load moving equipment, utilizing wheels and hovercraft technology, that move heavy, awkward, or delicate loads in factories. Companies large and small find benefit from our worldwide dealer network, experienced product specialists, and skilled engineers. We work with you to find a load moving solution that is safe, efficient and cost-effective, as your valuable loads are carried through the manufacturing process.

Magnolia Medical Technologies is on a Mission to ZERO®. Today, we offer healthcare institutions a solution to some of their biggest hidden problems – contamination leading to misdiagnosis of bloodstream infections, including sepsis, which can lead to unnecessary and prolonged antibiotic therapy, and false-positive CLABSIs. Tomorrow, we aspire to create a world free of in-vitro diagnostic errors where rapid, accurate test results improve the lives of patients and providers alike. We know that setting new standards of care is a journey enabled by purposeful innovation, partnerships, and perseverance. As the first step of our journey, we have successfully developed and proven our evidence-based technology platform, Steripath, which we’ve coupled with unparalleled support to change clinical practices and prevent unnecessary patient harm as well as system-wide costs associated with the misdiagnosis of sepsis. Our mission is further enabled by reducing false-positive CLABSIs and leveraging our extensive intellectual property portfolio – consisting of over 100 issued method, apparatus, and design patents and 70+ patent applications pending – to address other important sources of diagnostic error that are harmful to patients and costly to hospitals.

Lumicor designs, develops and manufactures innovative architectural panels, resin solutions, and dimensional wall tiles for architects and designers to enhance spaces with light, color, texture and shapes. Our architectural resin panels bring an element of design inspiration, mood and light play to interiors using natural, man-made and digitally inspired designs.